Sanjiv Patel - Feb 11, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
President and CEO, Director
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Feb 11, 2025
Transactions value $
-$818,400
Form type
4
Date filed
2/13/2025, 08:56 PM
Previous filing
Jan 23, 2025
Next filing
Apr 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$540K -140K -18.3% $3.85 626K Feb 11, 2025 Direct F1, F2
transaction RLAY Common Stock Award $0 +332K +53.11% $0.00 958K Feb 11, 2025 Direct F3, F4
transaction RLAY Common Stock Sale -$279K -75.3K -7.86% $3.70 883K Feb 13, 2025 Direct F5, F6
holding RLAY Common Stock 200K Feb 11, 2025 By The Patel Family Irrevocable Trust of 2019 F7
holding RLAY Common Stock 687K Feb 11, 2025 By The SSP Irrevocable Trust of 2020 F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 381,180 shares of restricted stock units ("RSUs") on February 10, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 381,180 shares underlying RSUs.
F3 Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F4 Includes 713,645 shares underlying RSUs.
F5 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 166,232 shares of RSUs on February 12, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F6 Includes 547,413 shares underlying RSUs.
F7 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.